SUSTAINED RELEASE ORAL MATRIX AND METHODS OF MAKING THEREOF

• US 20130028955A1
• Filed: 07/25/2011
• Published: 01/31/2013
• Est. Priority Date: 07/25/2011
• Status: Abandoned Application

• Current Assignee: Gaurav Thakersi Tolia
• Original Assignee: Gaurav Thakersi Tolia
• Inventors: Tolia, Gaurav Thakersi
• Application Number:
  US13/190,398
• Publication Number:
  US 20130028955A1
• Time in Patent Office: Days
• US Class Current: 424/450
• CPC Class Codes: A61K 31/167 having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
• CPC Class Codes: A61K 31/196 the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
• CPC Class Codes: A61K 31/277 having a ring, e.g. verapamil
• CPC Class Codes: A61K 31/573 substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
• CPC Class Codes: A61K 31/60 Salicylic acid; Derivatives thereof
• CPC Class Codes: A61K 9/2027 obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
• CPC Class Codes: A61K 9/2036 Silicones; Polysiloxanes
• CPC Class Codes: A61P 25/06 Antimigraine agents
• CPC Class Codes: A61P 25/08 Antiepileptics; Anticonvulsants
• CPC Class Codes: A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
• CPC Class Codes: A61P 3/04 Anorexiants; Antiobesity agents
• CPC Class Codes: A61P 3/10 for hyperglycaemia, e.g. antidiabetics
• CPC Class Codes: A61P 31/04 Antibacterial agents
• CPC Class Codes: A61P 31/10 Antimycotics
• CPC Class Codes: A61P 31/12 Antivirals
• CPC Class Codes: A61P 33/02 Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
• CPC Class Codes: A61P 35/00 Antineoplastic agents
• CPC Class Codes: A61P 7/02 Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
• CPC Class Codes: A61P 9/06 Antiarrhythmics

Abstract

A solid dosage form suitable for forming a tablet for the containment and delivery of medicament is provided wherein the matrix forming material is a pressure sensitive adhesive, present in the amount from about 0.1 to about 40 weight %, based on the total weight of the composition. The dosage form is comprised of the medicament and a water-insoluble polymer silicone pressure sensitive adhesive and allows release of the medicament in a controlled fashion depending on simple parameters such as weight percent of the polymer silicone adhesive. A sustained release dosage form is provided for delivery of medicament wherein the release rate of medicament does not depend on the dissolution medium of the pH. Another aspect of invention is formation of solid tablets of poorly compressible material and the method for making the solid composition. The dosage form for this invention s particularly suitable for oral dosage forms.

Claims

1. A solid tablet for controlled release of active medicaments comprising one or more active pharmaceutically agent in an amount sufficient to provide a therapeutic effect when administered and at least a pressures sensitive adhesive.

2. The solid tablet of claim 1 wherein the pressure sensitive adhesive is a silicone pressure sensitive adhesive selected from a silicone/resin copolymer with silicon-bonded hydroxyl radicals, a silicone/resin copolymer with end capped silicon-bonded hydroxyl radicals and mixtures thereof.

3. The solid tablet of claim 2 wherein the pressure sensitive adhesive is an silicone pressure sensitive adhesive selected from a silicone/resin copolymer and has 40 to 70 parts by weight of at least one resin copolymer and 30 to 70 parts by weight of polydiorganosiloxane comprising ARSiO units.

4. A composition according to claim 2, wherein the silicone/resin copolymer is prepared by polycondensation of the silanol endblocked polydialkylsiloxane with a hydroxyl end-blocked silicate resin.

5. The solid tablet of claim 1 wherein the pressure sensitive adhesive is an acrylic pressure sensitive adhesive comprising about 5 to about 100 weight percent of (meth)acrylic acid copolymer cross-linked with a crosslinking agent.

6. The solid tablet of claim 1 wherein the active pharmaceutical agent is selected from the group consisting of analgesics, anti-inflammatory agents, antihelmimthics, anti-arrhythmic agents, anti-bacterial agents, anti-viral agents, anti-coagulants, anti-depressants, anti-diabetics, anti-epileptics, anticancer agent, anti-fungal agents, anti-gout agents, antihypertensive agents, anti-malariale, anti-migrainc agents, anti-muscarinic agents, anti-neoplastic agents, erectile dysfunction improvement agents, immunosuppressants, antiprotozoal agents, anti-thyroid agents, anxiolytic agents, sedatives, hypnotics, neuroleptics, (3-Blockers, cardiac inotropic agents, corticosteroids, diuretics, anti-parkinsonian agents, gastro-intestinal agents, histamine receptor antagonists, keratolytics, lipid regulating agents, anti-anginal agents, cox-2 inhibitors, antioxidant agent, leukotriene inhibitors, macrolides, muscle relaxants, nutritional agents, opioid analgesics, protease inhibitors, sex hormones, stimulants, muscle relaxants, anti-osteoporosis agents, anti-obesity agents, cognition enhancers, anti-urinary incontinence agents, nutritional oils, anti-benign prostate hypertrophy agents, a hormone, a steroid, steroid antagonist, a vitamin, essential fatty acids, non-essential fatty acids, and mixtures thereof.

7. The solid tablet of claim 6 wherein the active pharmaceutical agent is poorly compressible.

8. A solid tablet for controlled release of active medicaments of claim 1 wherein the pressures sensitive adhesive comprises from about 0.1 to about 40 weight %, based on the total weight of the composition for aiding compression and controlling medicament release.

11. A method according to claim 1 for controlled and sustained release of medicaments for oral drug delivery delivered from a tablet compromising of silicone pressure sensitive adhesive and at least one active medicament.

12. A method according to claim 1 for controlled and sustained release of medicaments for oral delivery from a tablet along the oral route comprising of a pressure sensitive adhesive, at least an active agent and at least one water soluble excipient comprising of:

(i) an anti-sticking agent, a glidant, a flow promoter, a lubricant, an anticoagulant, an antifoaming agent, an antioxidant, a binder, a buffering agents, a chelating agent, a coagulant, a colorant, a cryoprotectant, a diluent, a filler, a disintegrant, a flavorant, or sweetner, a plasticizer, a preservative and mixtures thereof.

15. A solid tablet of claim 1, wherein the active pharmaceutical agent is a salt form of the active agent.

16. A solid tablet of claim 1, wherein the active pharmaceutical agent is a weak acid, weak base, non ionizable or mixtures thereof.

19. A method for preparing the solid tablet according to claim 1, wherein the adhesive

(i) is a curable adhesive, cured either by using catalytic reaction, heat, oxidation, light or combinations thereof

(ii) is a cross-linked pressure sensitive adhesive.

9. A solid tablet for controlled release of active medicaments comprising one or more active pharmaceutically agent in an amount sufficient to provide a therapeutic effect when administered, an excipient and at least a pressures sensitive adhesive.

10. A solid tablet for controlled release of active medicaments of claim 9 wherein the pressures sensitive adhesive comprises from about 0.1 to about 40 weight %, based on the total weight of the composition, the active pharmaceutical agent comprises from about 10 to about 99 weight % based on the total weight of the composition and the excipient comprises from about 5 to about 70 weight % of the total weight of the composition.

13. A composition of claim 9, wherein a solubilizing agent is added to the oral tablet comprises from about 1 to about 70 weight percent of the total composition.

14. A composition according to claim 9, wherein the solubilizing agent is a complexing agent, surfactant, liposome, PEG derived fatty acids, buffering agent, glycols or sugars.

17. A method for preparing the oral tablet comprising the steps of:

(i) dissolving the pressure sensitive adhesive in appropriate solvent

(ii) forming a suspension of medicament in the adhesive/solvent solution

(iii) drying the suspension to obtain a solid matrix

(iv) compressing the matrix to form required shape and size of the oral dosage form

18. A method according to claim 17, wherein the solvent used for dissolving the polymer is selected consisting of hydrocarbon solvents, volatile silicones, non-hydrocarbon solvents and mixtures thereof.